NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

InspireMD, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.44−0.02 (-3.34%)

Close on Oct 19, 2026

Market cap: $37.25M
P/E (TTM): –
Dividend yield: –

Fundamental chart

Pick a measure to chart its full history

$8.98MFY2025, +7.7% a year since FY2009

Where these numbers come from

Parsed from the XBRL in InspireMD's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on May 10, 2021
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NSPR.

Revenue growth53.4% · median 0.5%

Gross margin18.1% · median 43.0%

Operating margin-494.0% · median -77.6%

Net margin-484.1% · median -86.7%

Company	Revenue	Growth
CVRX	$61.19M	+12.0%
SRTS	$17.51M	-53.4%
NSPR	$10.84M	+53.4%
MDNC	$10.21M	-10.9%
XAIR	$7.69M	+60.7%
BDMD	–	–

Company

Next earnings (est.): Nov 3, 2026, during market hours
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 127
Held by institutions: 53.6%
Auditor: Kesselman & Kesselman
SEC CIK: 1433607

Advertisement
300 × 250